Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Research
  • Published:

Evaluation of a progressive treatment program for erectile dysfunction in patients with diabetes mellitus

International Journal of Impotence Research volume 17, pages 431–436 (2005)Cite this article

Abstract

The aim was to evaluate the effectiveness of a progressive program, starting with simple methods and, when not effective, moving to more complex methods, to treat erectile dysfunction (ED) in patients with diabetes mellitus. A total of 284 diabetic patients with ED entered into a 6-phase program starting with sildenafil citrate (Viagra). Those with contraindications, side effects, or negative response (erection insufficient for vaginal penetration) were switched to the vacuum erection device (VED), and then progressively (for failures) to intracavernous injection (ICI), sildenafil citrate+ICI, ICI+VED, and penile prosthesis. Patients were followed for 2 y. Of the 284 patients 276 patients were eligible for sildenafil citrate and 147 (53.3%) responded positively, but 25 (9.1%) patients stopped it soon due to adverse effects. Of 162 patients (129 nonresponders, eight noneligible for the sildenafil and 25 patients who dropped out due to adverse effects), treated with VED, 114 (70.4%) responded well, however, only 19 (11.7%) patients agreed to continue its use. Of the remaining 143 patients (nonresponders, noneligible for the previously mentioned treatments and patients who dropped out due to adverse effects), 103/143 (72%) responded to ICI, 27/40 (67.5%) to sildenafil+ICI, and 9/13 (69.2%) to ICI+VED. Four patients received a penile implant. At the 2 y follow-up, 81 of 284 patients who entered the study (28.5%) were still responding to sildenafil, seven (2.5%) to VED, 113 (39.8%) to ICI, 24 (8.5%) to sildenafil+ICI, two (0.7%) to ICI+VED; 15 (5.3%) had a penile implant. In all 17 (6%) patients reported spontaneous erections, 11 (3.9%) stopped the treatment due to family reasons and 14 (4.9%) failed the treatment. In conclusion, the progressive treatment program for ED seems to be very effective for diabetic patients, yielded a complete response for short-term and 91.2% rate of success at the end of 2 y follow-up.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Benneff PH, Rewers MJ, Knowler WC . Epidemiology of diabetes mellitus. In: Porte D, Sherwin R (eds). Ellenberg & Rifkin's Diabetes Mellitus, 5th edn. Appleton & Lange: Stanford, CT, 1998, pp 373–385.

    Google Scholar 

  2. Hakim LS, Goldstein J . Diabetic sexual dysfunction. Endocr Metab Clin North Am 1996; 25: 379–400.

    Article  CAS  Google Scholar 

  3. Koppiker N, Boolell M, Price D . Recent advances in the treatment of erectile dysfunction in patients with diabetes mellitus. Endocr Pract 2003; 9: 52–63.

    Article  Google Scholar 

  4. De Berardis G et al. Erectile dysfunction and quality of life in type 2 diabetic patients. Diabetes Care 2003; 25: 284–291.

    Article  Google Scholar 

  5. De Berardis G et al. Identifying patients with type 2 diabetes with a higher likelihood of erectile dysfunction: the role of the interaction between clinical and psychological factors. J Urol 2003; 169: 1422–1428.

    Article  Google Scholar 

  6. Price DE et al. The management of impotence in diabetic men by vacuum tumescence therapy. Diabetes Med 1991; 8: 964–967.

    Article  CAS  Google Scholar 

  7. Bodansky HJ . Treatment of male erectile dysfunction using the active vacuum assist device. Diabetes Med 1994; 11: 410–412.

    Article  CAS  Google Scholar 

  8. Bell DS, Cutter GR, Hayne VB, Lloyd LK . Factors predicting efficacy of phentolamine-papaverine intracorporeal injection for treatment of erectile dysfunction in diabetic males. Urology 1992; 40: 36–69.

    Article  CAS  Google Scholar 

  9. Segenreich E et al. Comparative evaluation of treatment of 452 patients suffering from various forms of erectile dysfunction with vasoactive agents injected intracorporally. Harefuah 1998; 134: 673–678.

    CAS  PubMed  Google Scholar 

  10. Lipshultz LJ, Kim ED . Treatment of erectile dysfunction in men with diabetes. JAMA 1999; 281: 465–470.

    Article  CAS  Google Scholar 

  11. Boulton AJM, Selam JL, Sweeney M, Ziegler D . Sildenafil citrate for the treatment of erectile dysfunction in men with type II diabetes mellitus. Diabetologia 2001; 44: 1296–1301.

    Article  CAS  Google Scholar 

  12. Brock GB et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol 2002; 163: 1332–1336.

    Article  Google Scholar 

  13. Goldstein I et al. The Vardenafil Diabetes Study Group: Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes. Diabetes Care 2003; 26: 777–783.

    Article  CAS  Google Scholar 

  14. Chen J, Mabjeesh NJ, Greenstein A . Sildenafil versus the vacuum erection device: patient preference. J Urol 2001; 166: 1779–1781.

    Article  CAS  Google Scholar 

  15. McMahon CG, Samali R, Johnson H . Treatment of intracorporeal injection nonresponse with sildenafil alone or in combination with triple agent intracorporeal injection therapy. J Urol 1999; 162: 1992–1997.

    Article  CAS  Google Scholar 

  16. Carson CC, Mulcahy JJ, Govier FE, AMS 700 CX Study Group. Efficacy, safety and patient satisfaction outcomes of the AMS 700 CX inflatable penile prosthesis: results of a long-term multicenter study. Urology 2000; 164: 376–380.

    Article  CAS  Google Scholar 

  17. Cappelleri JC et al. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 1999; 54: 346–351.

    Article  CAS  Google Scholar 

  18. Segenreich E, Israilov SR, Shmueli J, Servadio C . Can the vacuum test be used as a diagnostic method for determining the degree of severity of erectile dysfunction. Int J Impotence Res 1994; 6: 99–166.

    CAS  Google Scholar 

  19. DeBusk R et al. Management of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton Consensus Panel. Am J Cardiol 2000; 86: 175–181.

    Article  CAS  Google Scholar 

  20. Bland M . An Introduction to Medical Statistics. Oxford University Press: Oxford, 1989, pp 22–104.

    Google Scholar 

  21. Carson CC, Burnett AL, Levine LA, Nehra A . The efficacy of sildenafil citrate (Viagra®) in clinical populations: an update. Urology 2002; 60: 12–27.

    Article  Google Scholar 

  22. Levine LA, Dimitrou RJ . Vacuum constriction and external erection devices in erectile dysfunction. Urol Clin North Am 2001; 28: 335–341.

    Article  CAS  Google Scholar 

  23. Sarteschi LM et al. Cavernous arterial and arteriolar circulation in patients with erectile dysfunction: a power Doppler study. J Urol 1998; 159: 428–432.

    Article  CAS  Google Scholar 

  24. Wilson SK, Carson CC, Cleves MA, Delk II JR . Quantifying risk of penile prosthesis infection with elevated glycosylated hemoglobin. J Urol 1998; 159: 1537–1540.

    Article  CAS  Google Scholar 

  25. Grunwald JE, Metelitsina T, Grunwald L . Effect of sildenafil citrate (Viagra) on retinal blood vessel diameter. Am J Ophthalmol 2002; 133: 809–812.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Urology, Rabin Medical Center, Beilinson Campus, Petah Tiqwa, Israel

    S Israilov, J Shmuely, D Engelstein, P Livne & J Boniel

  2. Department of Medicine, Sapir Medical Center, Meir Hospital, Kfar-Sabo, Israel

    E Niv

Authors
  1. S Israilov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J Shmuely
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E Niv
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D Engelstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P Livne
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J Boniel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S Israilov.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Israilov, S., Shmuely, J., Niv, E. et al. Evaluation of a progressive treatment program for erectile dysfunction in patients with diabetes mellitus. Int J Impot Res 17, 431–436 (2005). https://doi.org/10.1038/sj.ijir.3901337

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3901337

Keywords

This article is cited by

Search

Advanced search

Quick links